Affectionately nicknamed the “Viagra condom”, this new contraceptive has relatively little to do with pharmaceutical company Pfizer’s erectile dysfunction treatment; but will have similar results for users.
The product, called CSD500, is lined with a vasodilating gel which increases blood flow to the penis and helps maintain an erection. But unlike the famous blue diamond pill Viagra, CSD500 will be aimed at men who have trouble specifically maintaining erections when using a condom.
The biotechnology company Futura Medical, which is owned by consumer-products company Reckitt Benckiser, who developed the new condom, hopes that this will also promote safer sex as men would be attracted to the idea of longer lasting erections. The most difficult task they faced wasn't creating an effective contraceptive condom, but one that isn't affected by the enhancing gel.
Posts
Post a Comment